Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Sensitivity, Specificity and Potential for Clinical Use.

MLA

d’Abramo, Cristina, et al. “Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Sensitivity, Specificity and Potential for Clinical Use.” Journal of Personalized Medicine, vol. 10, no. 3, Sept. 2020, p. 116. EBSCOhost, https://doi.org/10.3390/jpm10030116.

APA

d’Abramo, C., D’Adamio, L., & Giliberto, L. (2020). Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Sensitivity, Specificity and Potential for Clinical Use. Journal of Personalized Medicine, 10(3), 116. https://doi.org/10.3390/jpm10030116

Chicago

d’Abramo, Cristina, Luciano D’Adamio, and Luca Giliberto. 2020. “Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Sensitivity, Specificity and Potential for Clinical Use.” Journal of Personalized Medicine 10 (3): 116. doi:10.3390/jpm10030116.